Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options
Joseph Burnett(University of Michigan), Duxin Sun(University of Michigan)
Cited by 62
Related Papers
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
|Nature Chemical Biology|2023|62
Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells
|Oncology Reports|2018|27
A gastrointestinal locally activating Janus kinase inhibitor to treat ulcerative colitis
|Journal of Biological Chemistry|2023|7
Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0